These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8734330)

  • 1. [Suppression of platelet activating factor effects (PAF) on the retina by G-proteins inhibitors].
    Doly M; Oustrin J
    Ann Pharm Fr; 1996; 54(2):64-7. PubMed ID: 8734330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet-activating factor-induced retinal impairments by cholera and pertussis toxins.
    Cluzel J; Doly M; Bazan NG; Bonhomme B; Braquet P
    Ophthalmic Res; 1995; 27(3):153-7. PubMed ID: 8538992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Involvement of PAF (Platelet-Activating Factor) in chloroquine-induced retinopathy].
    Meyniel G; Doly M; Millerin M; Braquet P
    C R Acad Sci III; 1992; 314(2):61-5. PubMed ID: 1559183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of PAF-acether on electrophysiological response of isolated retina.
    Doly M; Braquet P; Bonhomme B; Meyniel G
    Int J Tissue React; 1987; 9(1):33-7. PubMed ID: 3596955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of vincristine-induced retinal impairments by a specific PAF antagonist.
    Doly M; Millerin M; Bonhomme B; Droy-Lefaix MT; Braquet P
    Lens Eye Toxic Res; 1992; 9(3-4):529-35. PubMed ID: 1301801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium.
    Tao Y; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2037-46. PubMed ID: 8814143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730.
    Doly M; Cluzel J; Millerin M; Bonhomme B; Braquet P
    Ophthalmic Res; 1993; 25(5):314-8. PubMed ID: 8259265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activity.
    Castro-Faria-Neto HC; Martins MA; Silva PM; Bozza PT; Cruz HN; de Queiroz-Paulo M; Kaplan MA; Cordeiro RS
    J Lipid Mediat; 1993 May; 7(1):1-9. PubMed ID: 8358020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
    Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
    Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J; Giri SN
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
    Saeed SA; Rasheed H
    Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
    Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
    Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
    Bennett SA; Birnboim HC
    Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antagonistic effect of myricetin on platelet activing factor].
    Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
    Yao Xue Xue Bao; 2003 Nov; 38(11):831-3. PubMed ID: 14991995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
    Beauchamp MH; Marrache AM; Hou X; Gobeil F; Bernier SG; Lachapelle P; Abran D; Quiniou C; Brault S; Peri KG; Roberts J; Almazan G; Varma DR; Chemtob S
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3327-37. PubMed ID: 12356842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory.
    Teather LA; Packard MG; Bazan NG
    Neurobiol Learn Mem; 1998 Nov; 70(3):349-63. PubMed ID: 9774526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor (PAF) modulates peritoneal mouse macrophage infection by Leishmania amazonensis.
    Rosa MS; Vieira RB; Pereira AF; Dutra PM; Lopes AH
    Curr Microbiol; 2001 Jul; 43(1):33-7. PubMed ID: 11375661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.